Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
Vaxart, Inc. issued 447,067 shares of Common Stock (the "Commitment Shares") of common stock to Lincoln Park Capital Fund, LLC for Lincoln Park committed to purchase up to $25.0 million of the Company’s common stock.
- Security
- common stock
- Shares
- 447,067 shares of Common Stock (the "Commitment Shares")
- Purchaser
- Lincoln Park Capital Fund, LLC
- Consideration
- Lincoln Park committed to purchase up to $25.0 million of the Company’s common stock
Exact text from the filing
rights agreement (the “ Registration Rights Agreement ”), with Lincoln Park Capital Fund, LLC (“ Lincoln Park ”), pursuant to which Lincoln Park committed to purchase up to $25.0 million of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”), subject to certain limitations and satisfaction of the conditions set forth in the Purchase
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Vaxart, Inc. entered into Purchase Agreement with Lincoln Park Capital Fund, LLC valued at up to $25.0 million (effective 2026-04-16).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- Lincoln Park Capital Fund, LLC
- Value
- up to $25.0 million
- Effective
- 2026-04-16
Exact text from the filing
On April 16, 2026, Vaxart, Inc. (the “Company”) entered into a purchase agreement (the “ Purchase Agreement ”) and a registration rights agreement (the “ Registration Rights Agreement ”), with Lincoln Park Capital Fund, LLC (“ Lincoln Park ”), pursuant to which Lincoln Park committed to purchase up to $25.0 million of the Company’s common stock
View on SEC.gov